AMR Logo.png
Global Coagulation Testing Market to Reach $8.8 Billion by 2031: Allied Market Research
November 28, 2022 05:32 ET | Allied Market Research
Portland, OR, Nov. 28, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Coagulation Testing Market generated $3.1 billion in 2021, and is...
AMR Logo.png
Flow Diverters Market to Hit $1.04 Billion, with CAGR of 15.3% by 2031: Allied Market Research
November 27, 2022 19:00 ET | Allied Market Research
Portland, OR, Nov. 27, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Flow Diverters Market generated $251.50 million in 2021, and is...
AMR Logo.png
Telepsychiatry Market Size is Expected to Reach $41.8 Billion by 2031: Says AMR
November 16, 2022 02:53 ET | Allied Market Research
Portland, OR, Nov. 16, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Telepsychiatry Market was estimated at $6.5 billion in 2021 and is...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bed Bath & Beyond, Sema4, Medtronic, and Palantir and Encourages Investors to Contact the Firm
November 06, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm
October 31, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
logo-alt.png
Smart Pills Market is estimated to be US$ 2068.48 million by 2032 with a CAGR of 15.4% over the forecast period - By PMI
October 28, 2022 09:02 ET | PMI
Covina, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Smart Pills Market accounted for US$ 497.2 million in 2022 and is estimated to be US$ 2068.48 million by 2032 and is anticipated to register a CAGR of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm
October 26, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic, Palantir, Fulgent, and Yatsen and Encourages Investors to Contact the Firm
October 21, 2022 21:00 ET | Bragar Eagel & Squire
NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
logo-alt.png
Drug Eluting Stent Market is estimated to be US$ 14.02 billion by 2032 with a CAGR of 6.5% during the forecast period 2032 - By PMI
October 19, 2022 09:03 ET | PMI
Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
October 16, 2022 23:37 ET | Bragar Eagel & Squire
NEW YORK, Oct. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...